Oxford Biomedica (LSE: OXB), an innovative leading viral vector specialist focused on delivering life changing therapies to patients.
Employees: 501-1000
Total raised: $15.33M
Founded date: 1995
Investors 2
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| 20.02.2021 | Vitruvian ... | vitruvianp... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.01.2018 | Grant | $4.27M | - |
| 11.09.2013 | - | $11.06M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 20.02.2023 | Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 M... | Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023 Dr Mathias brings a wealth of ... | einpresswi... |
| 15.09.2022 | OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDE... | OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022 SIGNIFICANT STRATEGIC AN... | globenewsw... |
| 04.02.2022 | Oxford Biomedica raises £39m after snapping up majority stak... | Oxford Biomedica, which helped AstraZeneca with its Covid-19 vaccine manufacturing, has raised £39.4... | cityam.com... |
| 14.12.2021 | Oxford Biomedica : Appoints Catherine Moukheibir as Non-Exec... | Oxford, UK - [14] December 2021: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or &qu... | marketscre... |
| 08.11.2021 | Sanofi eyes a gene therapy prospect and commits $60M for a s... | Sanofi’s gene therapy pipeline is not as deep as that of some of its industry peers, and the company... | medcitynew... |
| 19.10.2021 | Oxford Biomedica : Boehringer Ingelheim Exercises Option | Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene T... | marketscre... |
| 23.09.2021 | Serum Institute to invest $68 million in UK vaccine maker Ox... | Serum Life Sciences, a unit of SII, will pick up a 3.9% stake in Oxford Biomedica as part of the dea... | thehindubu... |
| 23.09.2021 | Oxford Biomedica sees new investment for manufactur... | Oxford Biomedica has landed some new cash. The British gene and cell therapy biotech announc... | endpts.com... |
| 22.09.2021 | Oxford Biomedica Plc INTERIM RESULTS FOR THE SIX MONTHS ENDE... | OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 Oxford Biomedica deliver... | marketscre... |
| 22.09.2021 | Oxford Biomedica : announces strategic investment by Serum L... | The information contained within this announcement is deemed by the Group to constitute inside infor... | marketscre... |
Show more